(-0.46%) 5 048.42 points
(-0.98%) 38 086 points
(-0.64%) 15 612 points
(1.21%) $83.81
(-2.60%) $1.610
(0.26%) $2 344.40
(0.35%) $27.44
(1.01%) $925.05
(-0.30%) $0.932
(-0.21%) $10.96
(-0.39%) $0.799
(-0.06%) $92.27
@ $236.10
Issued: 25 Apr 2024 @ 15:08
Return: -0.06%
Previous signal: Apr 24 - 14:57
Previous signal:
Return: -1.18 %
Live Chart Being Loaded With Signals
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally...
Stats | |
---|---|
Today's Volume | 361 149 |
Average Volume | 465 895 |
Market Cap | 11.10B |
EPS | $0 ( 2024-02-21 ) |
Next earnings date | ( $5.63 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.91 |
ATR14 | $3.86 (1.64%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-22 | Dwek Raymond | Buy | 3 000 | Common Stock |
2024-04-22 | Dwek Raymond | Sell | 3 000 | Common Stock |
2024-04-22 | Dwek Raymond | Sell | 3 000 | Share Tracking Award |
2024-04-19 | Rothblatt Martine A | Sell | 3 600 | Stock Options |
2024-04-22 | Rothblatt Martine A | Sell | 3 600 | Stock Options |
INSIDER POWER |
---|
-43.83 |
Last 100 transactions |
Buy: 94 260 | Sell: 241 320 |
Volume Correlation
United Therapeutics Corp Correlation
10 Most Positive Correlations | |
---|---|
BOCH | 0.917 |
PUI | 0.882 |
ISRG | 0.874 |
SHSP | 0.864 |
MMAC | 0.852 |
HALO | 0.85 |
HOUR | 0.838 |
IMKTA | 0.837 |
IBCP | 0.837 |
FENC | 0.83 |
10 Most Negative Correlations | |
---|---|
GAINL | -0.934 |
APOP | -0.93 |
TDAC | -0.928 |
RMRM | -0.876 |
ISNS | -0.861 |
CMLF | -0.852 |
INZY | -0.826 |
NTEC | -0.819 |
MAGS | -0.814 |
SVOK | -0.813 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
United Therapeutics Corp Correlation - Currency/Commodity
United Therapeutics Corp Financials
Annual | 2023 |
Revenue: | $2.33B |
Gross Profit: | $2.07B (88.94 %) |
EPS: | $21.04 |
Q4 | 2023 |
Revenue: | $614.70M |
Gross Profit: | $543.70M (88.45 %) |
EPS: | $4.62 |
Q3 | 2023 |
Revenue: | $609.40M |
Gross Profit: | $539.30M (88.50 %) |
EPS: | $5.71 |
Q2 | 2023 |
Revenue: | $596.50M |
Gross Profit: | $532.40M (89.25 %) |
EPS: | $5.53 |
Financial Reports:
No articles found.
United Therapeutics Corp
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators